30
Views
40
CrossRef citations to date
0
Altmetric
Research Article

Psycotherapeutic Possibilities of New Fantasy-Enhancing Drugs

Pages 209-224 | Published online: 25 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Thomas K. Brown, Geoff E. Noller & Julie O. Denenberg. (2019) Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder. Journal of Psychoactive Drugs 51:2, pages 155-165.
Read now
V. Kontrimavičiūtė, O. Mathieu, L. Balas, R. Escale, Jean Pierre Blayac & F.M. M. Bressolle. (2007) Ibogaine and Noribogaine: Structural Analysis and Stability Studies. Use of LC‐MS to Determine Alkaloid Contents of the Root Bark of Tabernanthe Iboga . Journal of Liquid Chromatography & Related Technologies 30:8, pages 1077-1092.
Read now
DennisJ. McKenna & G. H.N. Towers. (1984) Biochemistry and Pharmacology of Tryptamines and β-Carbolines A Minireview. Journal of Psychoactive Drugs 16:4, pages 347-358.
Read now

Articles from other publishers (36)

Alice Chirico, Marta Pizzolante, Alexandra Kitson, Elena Gianotti, Bernhard E. Riecke & Andrea Gaggioli. (2022) Defining Transformative Experiences: A Conceptual Analysis. Frontiers in Psychology 13.
Crossref
Martie S. Underwood, Stephen J. Bright & B. Les Lancaster. (2021) A narrative review of the pharmacological, cultural and psychological literature on ibogaine. Journal of Psychedelic Studies 5:1, pages 44-54.
Crossref
Maja KohekMaurice Ohren, Paul HornbyMiguel Ángel Alcázar‐Córcoles & José Carlos Bouso. (2020) The Ibogaine Experience: A Qualitative Study on the Acute Subjective Effects of Ibogaine. Anthropology of Consciousness 31:1, pages 91-119.
Crossref
Matteo Polit, Fabio Friso & Jacques Mabit. (2019) Plant based assisted therapy for the treatment of substance use disorders part 2 : beyond blurred boundaries.. Cultura y Droga 24:28, pages 19-42.
Crossref
Eduardo Ekman Schenberg, Maria Angélica de Castro Comis, João Felipe Morel Alexandre, Luís Fernando Tófoli, Bruno Daniel Rasmussen Chaves & Dartiu Xavier da Silveira. (2017) A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment. Journal of Psychedelic Studies 1:2, pages 74-83.
Crossref
Katarzyna Stebelska & Krzysztof Łabuz. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 875 889 .
Aleksandra Nikolić-Kokić, Zorana Oreščanin-Dušić, Ivan Spasojević, Marija Slavić, Ana Mijušković, Roman Paškulin, Čedo Miljević, Mihajlo B. Spasić & Duško P. Blagojević. (2015) Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes. Journal of Ethnopharmacology 164, pages 64-70.
Crossref
Beatriz Caiuby Labate, Rafael Guimarães dos Santos, Rick Strassman, Brian T. Anderson & Suely Mizumoto. 2014. The Therapeutic Use of Ayahuasca. The Therapeutic Use of Ayahuasca 153 159 .
Roman Paškulin, Polona Jamnik, Tjaša Danevčič, Gordana Koželj, Rok Krašovec, Dijana Krstić-Milošević, Duško Blagojević & Borut Štrukelj. (2012) Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga. Journal of Ethnopharmacology 143:1, pages 319-324.
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse 867 872 .
Deborah C. Mash. 2010. Clinical Addiction Psychiatry. Clinical Addiction Psychiatry 50 60 .
R Mačiulaitis, V Kontrimavičiūtė, FMM Bressolle & V Briedis. (2008) Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review. Human & Experimental Toxicology 27:3, pages 181-194.
Crossref
V. Kontrimavičiūtė, H. Breton, F. Barnay, J. C. Mathieu-Daudé & F. M. M. Bressolle. (2006) Liquid Chromatography-Electrospray Mass Spectrometry Determination of Ibogaine and 12-Hydroxy-Ibogamine in Human Urine. Chromatographia 63:11-12, pages 533-541.
Crossref
Violeta Kontrimavičiūtė, Michel Larroque, Vitalis Briedis, Delphine Margout & Françoise Bressolle. (2005) Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection. Journal of Chromatography B 822:1-2, pages 285-293.
Crossref
Agustin Olano & Isabel Martinez-Castro. 2004. Handbook of Food Analysis, Second Edition -3 Volume Set. Handbook of Food Analysis, Second Edition -3 Volume Set 1855 1890 .
Beth Levant & Thomas L. Pazdernik. (2004) Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats. Brain Research 1003:1-2, pages 159-167.
Crossref
E.A Carlini. (2003) Plants and the central nervous system. Pharmacology Biochemistry and Behavior 75:3, pages 501-512.
Crossref
Kenneth R Alper, Dana Beal & Charles D Kaplan. 2001. 249 281 .
Piotr Popik & Malgorzata Wróbel. 2001. 227 233 .
Michael H Baumann, John Pablo, Syed F Ali, Richard B Rothman & Deborah C Mash. 2001. 79 113 .
Scott Helsley, Richard A Rabin & J.C Winter. 2001. 63 77 .
Kenneth R Alper. 2001. 1 38 .
Richard A. Glennon, Malgorzata Dukat, Brian Grella, Seoung-Soo Hong, Luca Costantino, Milt Teitler, Carol Smith, Chris Egan, Katherine Davis & Mariena V. Mattson. (2000) Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug and Alcohol Dependence 60:2, pages 121-132.
Crossref
Birgit Rönner, Holger Lerche, Wolfgang Bergmüller, Christine Freilinger, Theodor Severin & Monika Pischetsrieder. (2000) Formation of Tetrahydro-β-carbolines and β-Carbolines during the Reaction of l -Tryptophan with d -Glucose . Journal of Agricultural and Food Chemistry 48:6, pages 2111-2116.
Crossref
Piotr Popik & Phil Skolnick. 1999. 197 231 .
Brian Grella, Malgorzata Dukat, Richard Young, Milt Teitler, Katharine Herrick-Davis, Colleen B Gauthier & Richard A Glennon. (1998) Investigation of hallucinogenic and related β-carbolines. Drug and Alcohol Dependence 50:2, pages 99-107.
Crossref
Scott Helsley, Richard A Rabin & J.C Winter. (1998) The effects of β-carbolines in rats trained with ibogaine as a discriminative stimulus. European Journal of Pharmacology 345:2, pages 139-143.
Crossref
FRANK J. VOCCI & EDYTHE D. LONDON. (1997) Assessment of Neurotoxicity from Potential Medications for Drug Abuse: Ibogaine Testing and Brain Imaging. Annals of the New York Academy of Sciences 820:1 Imaging Brain, pages 29-40.
Crossref
Samuel B Kombian, Tarek M Saleh, N.I.Yao Fiagbe, Xihua Chen, John J Akabutu, John K Buolamwini & Quentin J Pittman. (1997) Ibogaine and a Total Alkaloidal Extract of Voacanga africana Modulate Neuronal Excitability and Synaptic Transmission in the Rat Parabrachial Nucleus In Vitro. Brain Research Bulletin 44:5, pages 603-610.
Crossref
Henry Sershen, Audrey Hashim & Abel Lajtha. (1997) Ibogaine and Cocaine Abuse: Pharmacological Interactions at Dopamine and Serotonin Receptors. Brain Research Bulletin 42:3, pages 161-168.
Crossref
Lawrence J. Wichlinski. (1996) Possible involvement of an endogenous benzodiazepine receptor ligand of the inverse agonist type in the regulation of rapid-eye movement (REM) sleep: An hypothesis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 20:1, pages 1-44.
Crossref
F. Musshoff, Th. Daldrup & W. Bonte. (1993) Gas chromatographic—mass spectrometric screening procedure for the identification of formaldehyde-derived tetrahydro-β-carbolines in human urine. Journal of Chromatography B: Biomedical Sciences and Applications 614:1, pages 1-6.
Crossref
Edward Castan˜eda, Ian Q. Whishaw & Terry E. Robinson. (1992) Recovery from lateralized neocortical damage: dissociation between amphetamine-induced asymmetry in behavior and striatal dopamine neurotransmission in vivo. Brain Research 571:2, pages 248-259.
Crossref
D. W. Shoemaker, J. T. Cummins, T. G. Bidder, H. G. Boettger & M. Evans. (1980) Identification of harman in the rat arcuate nucleus. NaunynSchmiedeberg's Archives of Pharmacology 310:3, pages 227-230.
Crossref
ALEXANDER T. SHULGIN. 1976. Psychopharmacological Agents. Psychopharmacological Agents 59 146 .
Joseph D. Sapira & Robert H. McDonaldJr.Jr.. (1970) Drug Abuse—1970. Disease-a-Month 16:11, pages 1-47.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.